Position in NAMS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$464,293
+$147,394 QoQ
Shares Held
13,700
+38.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 198 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KLP KAPITALFORVALTNING AS holds $275,863,579 across 151 Biotechnology names. NAMS ranks #72 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
104,741 | $52,027,996 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
71,388 | $44,513,273 | |
| 3 | INCY |
Incyte Corp
|
192,305 | $21,799,694 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
56,760 | $17,086,462 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
67,100 | $12,566,488 | |
| 6 | INSM |
INSMED Inc
|
86,700 | $9,243,954 | |
| 7 | RPRX |
Royalty Pharma plc
|
158,200 | $8,870,274 | |
| 8 | MRNA |
Moderna, Inc.
|
77,900 | $5,455,337 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,293 | 13,700 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $316,899 | 9,900 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $319,228 | 9,100 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $258,804 | 9,100 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $164,801 | 9,100 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $122,820 | 6,000 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $154,200 | 6,000 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||